| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.045 | 0.8 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.8 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.0065 | 0.8 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.006 | 0.8 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.9 |